#TTLC26@AMansfieldMD@MayoClinic presents highlights of current research in #pleuralmesothelioma targeting:
➡️ MTAP deletion (PRMT5i)
➡️ TROP2 (ADCs)
➡️ Argininosuccinate synthetase 1 (ASS1) deficiency (ADI-PEG20)
👉🏽still a lot of work to do to optimize surgery, early detection and treatment for pts w this rare disease @curemeso #lcsm
Dive into the complexities of mesothelioma, thymic cancers, and other uncommon thoracic cancers. Join moderator Dr. @marinagarassino and expert panelists Drs. @SheenaBhallaMD, @SBroderickMD, @ErinGillaspie, @AMansfieldMD, @jennifermarksmd, @dwightowenmd, and @Joshua_Reuss for this deep dive at #TexasLung26! We're making it easy: FREE REGISTRATION for a limited time to the 2-day CE-accredited conference April 9–11, 2026 at @acllive in Austin, TX. Grab your spot now with promo code FREECME! https://t.co/dzMIy2CY56 #LungCancer #RareTumors #ThoracicOncology
Congratulations to Dr. @zhang_yongchang and his prospective phase III trial showing the impact of time of infusion on survival with immunotherapy in NSCLC. A no cost intervention that can have a huge impact. One of the top #ASCO25 presentations for me this year.
Congratulations Kaushal! I’m proud of you. It is wonderful to see all of your hard work being recognized with this opportunity.
Thank you @aadel_chaudhuri for your co-mentorship!
Dear @IASLC members,
I am proud to support Dr. Adjei's nomination for the IASLC President-an outstanding mentor, a passionate patient advocate, a lifelong teacher, exceptional clinician and truly remarkable human being. Please join me in supporting his candidacy #LCSM@OncoAlert
Insightful discussion on rare thoracic malignancies - thymoma/thymic carcinoma & mesothelioma at #TexasLung25. Challenging malignancies to diagnose and treat, often requiring sub-specialty and multi-d input.
So grateful to the brave patients and their families that made this clinical trial possible, an entirely new way to restore sensitivity to immunotherapy using plasma exchange. @MayoClinic@MayoCancerCare@flscientist
Nat Comm https://t.co/LdrTp8CaUS
Excited to present our liquid biopsy research to the thoracic disease group across the enterprise @MayoCancerCare@MayoClinic!
Thank you especially to @AMansfieldMD for the invitation. ☺️
Even the most advanced cancer therapies can’t work if tumors don’t absorb them. Mayo Clinic researchers, led by @AMansfieldMD, are pioneering a strategy to help targeted treatments get inside cancer cells. Discover more: https://t.co/BowIWBW45D